2m 2m 2m 2m 2m 2m 2m
- $111.2MMarket Cap
- -99.09%1-Year Change
- Asset ManagementIndustry
Solana-A (HSDT)
Key Performance
More- Earnings Score: N/A
- Momentum Score: 61
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
Helius Announces FDA 510(k) Submission for PoNSĀ® Device Label Expansion in Stroke
Helius Medical Technologies filed a 510(k) submission to the FDA seeking expanded indication for its PoNS device to treat gait and balance deficits in chronic stroke patients, based on clinical trials demonstrating statistically significant improvements in functional gait assessment.
09/25/2025, 7:00 AM ⢠GlobeNewswire
Peers
Statistics
MoreInformation as of 06/03/2026
Company Profile
Solana Company operates as a listed digital asset treasury. The company enhances Solana tokens per share on the commercially viable blockchain for decentralized finance and consumer applications. It also focuses on neurological wellness. In addition, the company offers Portable Neuromodulation Stimulator, a non-implantable medical device, which delivers mild electrical stimulation to the surface of the tongue to provide treatment of gait deficit and chronic balance deficit. Solana Company is headquartered in Newtown, Pennsylvania.
Key Executives
- Dane Carl Andreeff
- Jeffrey S. Mathiesen
- Antonella Favit-Van Pelt
- Choon Wee Chee
- Agustina Gani Tjandrasuwita
Current Ownership Distribution
- Institutions28.8M (49.40%)
- Other15.1M (25.87%)
- Mutual Funds8.4M (14.30%)
- Insiders6.1M (10.42%)